Why Pacira BioSciences Stock Is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition

Barron's | Oct 8, 2026 1:29 PM EDT

Viatris has agreed to acquire Pacira BioXciences, acquiring its portfolio of non-opioid pain medications.